Dna X (SONM) Total Liabilities (2018 - 2026)

Dna X's Total Liabilities history runs 9 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• Quarterly Total Liabilities fell 86.71% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 86.71% YoY) and the FY2025 annual result came in at $50.6 million, up 11.41% from the prior year.
• Total Liabilities was $4.9 million for Q1 2026 at Dna X, down from $50.6 million in the prior quarter.
• Across five years, Total Liabilities topped out at $50.6 million in Q4 2025 and bottomed at $4.9 million in Q1 2026.
• A 5-year average of $32.4 million and a median of $33.6 million in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2025 — Total Liabilities surged 64.27% — and 2026, when it plunged 86.71%.
• Dna X's Total Liabilities stood at $33.6 million in 2022, then climbed by 0.1% to $33.7 million in 2023, then jumped by 34.93% to $45.4 million in 2024, then rose by 11.41% to $50.6 million in 2025, then slumped by 90.28% to $4.9 million in 2026.
• Business Quant data shows SONM's Total Liabilities at $4.9 million in Q1 2026, $50.6 million in Q4 2025, and $40.9 million in Q3 2025.